Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
Tubulin has been shown to be an effective target for the development of cytotoxic agents against prostate cancer. Previously, we reported that Lx2-32c is an anti-tubulin agent with high binding affinity to tubulin. In this study, we investigated the potential of Lx2-32c to act as an effective cytoto...
Main Authors: | Guangyao Lv, Dengjun Sun, Jingwen Zhang, Xiaoxia Xie, Xiaoqiong Wu, Weishuo Fang, Jingwei Tian, Chunhong Yan, Hongbo Wang, Fenghua Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383516300715 |
Similar Items
-
Preparation, pharmacokinetics, biodistribution, antitumor efficacy and safety of Lx2-32c-containing liposome.
by: Hongbo Wang, et al.
Published: (2014-01-01) -
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
by: Irene Dell’Anno, et al.
Published: (2022-05-01) -
LX-8000R and UriSed 2 fully automated urine analyzers comparison to manual microscopic examination
by: Evin Canpolat Erkan Revşa, et al.
Published: (2022-01-01) -
QTAIM investigation of bis(pyrazol-1-yl)methane derivative and its Zn(II) complexes (ZnLX2, X=Cl, Br or I)
by: Dehestani Maryam, et al.
Published: (2015-01-01) -
Structural insight into the stabilization of microtubules by taxanes
by: Andrea E Prota, et al.
Published: (2023-03-01)